Dynavax Technologies | 営業利益



Operating Profit 変化する 日付
AbbVie USD 3.73B 5.22B 2025-03
Adma Biologics USD 37.08M 2.56M 2024-12
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.51B 166M 2025-06
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Dynavax Technologies USD -23630000 22M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
Merck USD 6.36B 494M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD 4.86B 201M 2025-06
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12


Dynavax Technologies 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Aug 2025.